Compound Detail
CHEMBL3186849
CPI 613 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL3186849 |
| Name | CPI 613 |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | ZYRLHJIMTROTBO-UHFFFAOYSA-N |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
11
Publications
4
Known Names
11
Indications
Molecular Properties
388.6
MW (Da)
6.26
ALogP
3
HBA
1
HBD
37.3
PSA (Ų)
0.41
QED
1
Ro5 Violations
13
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Racemic |
Indications
Leukemia, Myeloid, Acute Pancreatic Neoplasms Carcinoma, Pancreatic Ductal Leukemia Lymphoma Lymphoma, Non-Hodgkin Myelodysplastic Syndromes Neoplasms Biliary Tract Neoplasms Colorectal Neoplasms Sarcoma
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 1 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 1 |
| 37939862 | 10.1016/j.bmcl.2023.129545 | HepG2 | 1 |
| 37939862 | 10.1016/j.bmcl.2023.129545 | K562 | 1 |
| 37939862 | 10.1016/j.bmcl.2023.129545 | MCF7 | 1 |
| 37939862 | 10.1016/j.bmcl.2023.129545 | MDA-MB-231 | 1 |
| 37939862 | 10.1016/j.bmcl.2023.129545 | A549 | 1 |
| 37939862 | 10.1016/j.bmcl.2023.129545 | PANC-1 | 1 |
Data from ChEMBL 36 via Core Engine